HMG CoA reductase inhibitors
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
SIMVASTATIN: products 61 to 73 of 73.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Taro-Simvastatin 10mg TabDIN 02265885 | Listed, not a benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Taro-Simvastatin 20mg TabDIN 02265893 | Listed, not a benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Taro-Simvastatin 40mg TabDIN 02265907 | Listed, not a benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Teva-Simvastatin 10mg TabDIN 02250152 | General benefit | $0.2023per source unit | Requirements & sourcesBuild cost plan |
| Teva-Simvastatin 20mg TabDIN 02250160 | General benefit | $0.2501per source unit | Requirements & sourcesBuild cost plan |
| Teva-Simvastatin 40mg TabDIN 02250179 | General benefit | $0.2501per source unit | Requirements & sourcesBuild cost plan |
| Teva-Simvastatin 5mg TabDIN 02250144 | General benefit | $0.1023per source unit | Requirements & sourcesBuild cost plan |
| Teva-Simvastatin 80mg TabDIN 02250187 | General benefit | $0.2501per source unit | Requirements & sourcesBuild cost plan |
| Zocor 10mg TabDIN 00884332 | General benefit | $0.2023per source unit | Requirements & sourcesBuild cost plan |
| Zocor 20mg TabDIN 00884340 | General benefit | $0.2501per source unit | Requirements & sourcesBuild cost plan |
| Zocor 40mg TabDIN 00884359 | General benefit | $0.2501per source unit | Requirements & sourcesBuild cost plan |
| Zocor 5mg TabDIN 00884324 | Listed, not a benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Zocor 80mg TabDIN 02240332 | Listed, not a benefit | No price in this record | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
Products assigned to this ATC category in the held Health Canada records. Combinations assigned to other categories are not included; search their ingredient or product name separately.
C10AA HMG CoA reductase inhibitors. Health Canada DPD extract 2026-09-02.
WHO Collaborating Centre for Drug Statistics Methodology, ATC/DDD Index, 2026-01-20
C10AA HMG CoA reductase inhibitors